CLINICAL TRIAL BIOREPOSITORY AND ARCHIVING SOLUTIONS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Clinical Trial Biorepository and Archiving Solutions Market, By Product (Preclinical Products and Clinical Products), By Phase (Phase I, Phase II, Phase III, Phase IV), By Services (Biorepository Services and Archiving Solution Services), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jul 2024
Code : CMI7134
Pages :140
Formats :
Excel and PDF
Industry : Medical Devices

Regional Analysis

Clinical Trial Biorepository and Archiving Solutions Market Regional Insights

To learn more about this report, request sample copy

North America currently dominates the global clinical trial biorepository and archiving solutions market, with an estimated market share of 41.1% in 2024 owing to heavy investments in clinical trials by pharmaceutical and biotech companies based in the U.S. and Canada. With the presence of top clinical research organizations, contract research organizations and CROs, North America has established itself as the leader in clinical trials conducted globally each year. According to a recent industry report, the U.S. accounted for over 50% of market share in 2021 due to well-established medical and academic institutions that conduct clinical research. Furthermore, presence of major market players such as Brooks Life Sciences, Tecan Trading AG and Hamilton Company in the region boosts demand for state-of-the-art biorepository solutions.

Asia Pacific has emerged as the fastest growing regional market for Clinical Trial Biorepository And Archiving Solutions over the past decade. Countries such as China, India, Japan and South Korea have witness immense development of their pharmaceutical, biologics and chemicals sectors.